156 related articles for article (PubMed ID: 9583721)
1. Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas.
Sierra A; Castellsagué X; Coll T; Mañas S; Escobedo A; Moreno A; Fabra A
Int J Cancer; 1998 Apr; 79(2):103-10. PubMed ID: 9583721
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
Sierra A; Castellsagué X; Escobedo A; Lloveras B; García-Ramirez M; Moreno A; Fabra A
Int J Cancer; 2000 Mar; 89(2):142-7. PubMed ID: 10754491
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas.
Méndez O; Máñas S; Peinado ; Fabra A; Escobedo A; Moreno A; Sierra A
Breast Cancer Res Treat; 2001 Jan; 65(2):171-7. PubMed ID: 11261833
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
[TBL] [Abstract][Full Text] [Related]
6. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
8. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
[TBL] [Abstract][Full Text] [Related]
9. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
11. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
van Slooten HJ; van de Vijver MJ; van de Velde CJ; van Dierendonck JH
Br J Cancer; 1998 Mar; 77(5):789-96. PubMed ID: 9514059
[TBL] [Abstract][Full Text] [Related]
12. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene.
Eguchi H; Suga K; Saji H; Toi M; Nakachi K; Hayashi SI
Cell Death Differ; 2000 May; 7(5):439-46. PubMed ID: 10800077
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
Gonidi M; Athanassiadou AM; Patsouris E; Tsipis A; Dimopoulos S; Kyriakidou V; Chelidonis G; Athanassiadou P
Pathol Res Pract; 2011 Jun; 207(6):377-82. PubMed ID: 21621926
[TBL] [Abstract][Full Text] [Related]
14. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
[TBL] [Abstract][Full Text] [Related]
15. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical status of p53, MDM2, bcl2, bax, and ER in invasive ductal breast carcinoma in Tunisian patients.
Baccouche S; Daoud J; Frikha M; Mokdad-Gargouri R; Gargouri A; Jlidi R
Ann N Y Acad Sci; 2003 Dec; 1010():752-63. PubMed ID: 15033823
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas.
Bukholm IR; Bukholm G; Nesland JM
APMIS; 2002 Mar; 110(3):214-20. PubMed ID: 12076274
[TBL] [Abstract][Full Text] [Related]
20. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
